Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Charles River Laboratories Inc
EIR
•Charles River Laboratories Inc•September 21, 2020

Charles River Laboratories Inc – FDA EIR, Sep 21, 2020

Record Details

An FDA inspection of Charles River Laboratories Inc. in Spencerville, OH, occurred from September 21 to October 1, 2020. This unannounced, critical Good Laboratory Practice (GLP) inspection focused on two nonclinical studies supporting a New Drug Application. While no formal FDA Form 483 was issued, the inspection identified several deviations and facility observations requiring attention. Key issues included protocol deviations in two studies (CMX001-NCA-106 and CMX001-NCA-123). For study 106, the final report omitted cell count data for Day 3, and several mice were underweight at dosing initiation, contrary to protocol. For study 123, some rabbits exceeded the required weight range, and bioanalytical sample collection times deviated from the protocol by varying minutes. General facility observations noted inadequate recordkeeping, with paper records in the archive not stored in protective bags. Personnel issues included one employee not changing gloves between handling control and test articles, and two not wearing required personal protective equipment. Equipment maintenance was also a concern, specifically a "filthy" bedding dispenser lacking cleaning records. Furthermore, multiple animal cages and a cage rack lacked proper sanitization cards, and non-functioning ceiling lights were observed in the clean cage storage area. Although a formal 483 was not issued, management committed to addressing the discussed items within 15 business days, and some SOP revisions were made during the inspection. The sponsor was notified of the data omission for study 106, with intent to inform the FDA.

Company
Charles River Laboratories Inc
Inspection date
September 21, 2020
Product type
drugs
Office
Cincinnati District Office
People
  • Geoffrey K. Kilili (investigator)
  • Karen M. Cooper (investigator)
View Company Profile

ID · fe4d7b04-a79b-4073-914f-ea25fbbe71f4

Other documents for Charles River Laboratories Inc
  • 483 - 2025-10-17October 17, 2025
  • 483 - 2025-02-07February 7, 2025
  • 483 - 2024-10-11October 11, 2024
  • 483 - 2023-08-25August 25, 2023
  • EIR - 2019-04-03April 3, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Charles River Laboratories Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.